|
Dr. Rahal is Director of the Infectious Disease Section of the New York Hospital Queens, Professor of Medicine at the Weill Medical College of Cornell University, President of New York Society of Infectious Diseases and internationally renowned expert in the field of infection control. Dr. Rahal was one of the first physicians to study West Nile virus (WNV) commencing in 1999, when the illness, which is carried by mosquitoes, was first detected in the United States. Dr. Rahal has conducted a nationwide clinical trail for therapy of WNV with interferon alpha-2b, using Shering Plough's product, Intron A, in an effort to treat hospitalized patients. | 